[PLX] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
14-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 22.06%
YoY- 4.52%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 35,075 9,588 8,617 14,183 8,753 16,085 8,549 156.94%
PBT 19,647 -2,936 -3,210 -3,567 -5,334 -2,286 -6,667 -
Tax 308 195 530 442 -190 416 908 -51.45%
NP 19,339 -3,131 -3,740 -4,009 -5,144 -2,702 -6,667 -
Tax Rate -1.57% - - - - - - -
Total Cost 15,736 12,719 12,357 18,192 13,897 18,787 15,216 2.27%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 55.14 -32.66 -43.40 -28.27 -58.77 -16.80 -77.99 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS 0.29 -0.05 -0.07 -0.08 -0.11 -0.06 -0.15 -
EPS Diluted 0.21 -0.05 -0.07 -0.08 -0.11 -0.06 -0.15 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.